Detalhe da pesquisa
1.
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post-Autologous Stem Cell Transplant Period.
Open Forum Infect Dis
; 10(10): ofad497, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869409
2.
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
Open Forum Infect Dis
; 10(11): ofad550, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023562